Jazz Pharmaceuticals Aktie
WKN DE: A1JS1K / ISIN: IE00B4Q5ZN47
|
24.02.2026 22:16:56
|
Jazz Pharmaceuticals Plc Q4 Profit Climbs
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) released earnings for its fourth quarter that Increases, from the same period last year
The company's earnings totaled $203.45 million, or $3.21 per share. This compares with $191.11 million, or $3.11 per share, last year.
Excluding items, Jazz Pharmaceuticals plc reported adjusted earnings of $420.88 million or $6.64 per share for the period.
The company's revenue for the period rose 10.2% to $1.19 billion from $1.08 billion last year.
Jazz Pharmaceuticals plc earnings at a glance (GAAP) :
-Earnings: $203.45 Mln. vs. $191.11 Mln. last year. -EPS: $3.21 vs. $3.11 last year. -Revenue: $1.19 Bln vs. $1.08 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Jazz Pharmaceuticals PLC
|
23.02.26 |
Ausblick: Jazz Pharmaceuticals verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
|
04.11.25 |
Ausblick: Jazz Pharmaceuticals stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Jazz Pharmaceuticals PLC
Aktien in diesem Artikel
| Jazz Pharmaceuticals PLC | 147,60 | 0,14% |
|